Domino E F, Domino S E, Smith R E, Domino L E, Goulet J R, Domino K E, Zsigmond E K
Clin Pharmacol Ther. 1984 Nov;36(5):645-53. doi: 10.1038/clpt.1984.235.
Plasma ketamine concentrations after diazepam and placebo pretreatment were examined in a double-blind, randomized, cross-over study. Eight healthy male subjects received either diazepam or a 0.9% NaCl placebo before ketamine and received the alternate combination 5 to 24 days later. Ten minutes before ketamine dosing, diazepam, 0.3 mg/kg, or placebo in equal volume was injected intravenously at a rate not exceeding 5 mg/min. Ketamine, 2.2 mg/kg iv, was injected over 1 min. For the clinically relevant period for anesthesia (1 to 30 min), diazepam-ketamine treatment resulted in higher plasma levels at most time points, but diazepam pretreatment did not alter plasma levels of metabolite KI and pseudometabolite KII nor the 24-hr urinary excretion of ketamine, KI, and KII. Ketamine kinetics followed a three-term exponential decline under both treatment conditions. After placebo-ketamine dosing, plasma t 1/2s were as follows: distribution (pi t 1/2) = 24.1 sec, redistribution (alpha t 1/2) = 4.68 min, and elimination (beta t 1/2) = 2.17 hr. After diazepam-ketamine dosing, t 1/2s were: pi t 1/2 = 25.0 sec, alpha t 1/2 6.37 min, and beta t 1/2 = 2.32 hr.
在一项双盲、随机、交叉研究中,检测了地西泮和安慰剂预处理后血浆氯胺酮浓度。8名健康男性受试者在氯胺酮给药前接受地西泮或0.9%氯化钠安慰剂,并在5至24天后接受交替组合。在氯胺酮给药前10分钟,以不超过5mg/min的速率静脉注射0.3mg/kg地西泮或等体积安慰剂。静脉注射2.2mg/kg氯胺酮,注射时间为1分钟。在临床相关的麻醉期(1至30分钟),地西泮-氯胺酮治疗在大多数时间点导致血浆水平更高,但地西泮预处理并未改变代谢物KI和假代谢物KII的血浆水平,也未改变氯胺酮、KI和KII的24小时尿排泄量。在两种治疗条件下,氯胺酮动力学均呈三相指数下降。安慰剂-氯胺酮给药后,血浆半衰期如下:分布半衰期(πt1/2)=24.1秒,再分布半衰期(αt1/2)=4.68分钟,消除半衰期(βt1/2)=2.17小时。地西泮-氯胺酮给药后,半衰期为:πt1/2 = 25.0秒,αt1/2 = 6.37分钟,βt1/2 = 2.32小时。